Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Mid-Cap · Baird

Baird Small/Mid Cap Growth Fund Investor Class (BSGSX)

Ticker BSGSX · Since 2018-10-31 · · Holdings as of Jun 30, 2026

Expense ratio
1.1%$110/yr per $10k
5-yr return
−1.4%annualized
1-yr return
−9.0%as of Dec 2025
Net assets
$77.5Mall share classes
Holdings
58

Bottom line

Is BSGSX a good fund? The bottom line

BSGSX is the Investor Class share class of Baird Small/Mid Cap Growth Fund, an actively managed mid-cap mutual fund from Baird.

Annual fees run 1.1% — about $110 a year on every $10,000 invested, more expensive than 69% of mid-cap funds we track.

It returned −9.0% over one year, −1.4% a year over five years (as of Dec 31, 2025, per its prospectus).

With $77.5 million in net assets and 58 holdings, its largest position is First American Government Obli (3.6%) and the top 10 make up 28.2% of the portfolio.

What to watch

  • 5-year return in the bottom quarter of its category
  • 12b-1 marketing fee of 0.25% a year

Updated Nov 19, 2026

What BSGSX invests in

The investment objective of the Baird Small/Mid Cap Growth Fund (the Fund) is to provide long-term growth of capital.

The Fund normally invests at least 80% of its net assets, plus any borrowings for investment purposes, in the equity securities of U.S. and foreign small- and mid-capitalization companies, principally common stocks and American Depositary Receipts (ADRs) that are traded on major U.S. exchanges. Although the Fund principally invests in U.S. companies, the Fund may invest up to 15% of its total assets in equity securities (consisting of common stocks, ordinary shares and ADRs) of foreign companies. The Fund defines small- and mid-capitalization companies as those companies with a market capitalization within the range of companies in the Russell 2500 Growth Index at the time of investment. When analyzing equity securities to be purchased by the Fund, the Advisor emphasizes a companys growth prospects. The Funds investments are selected using a variety of both quantitative techniques and…

From the fund's prospectus (filed May 4, 2026).

BSGSX performance

Average annual total returns
1 yr5 yr10 yr
BSGSX−9.0%−1.4%—
Mid-Cap median+7.9%+8.1%+9.9%

Source: Fund prospectus, as of Dec 31, 2025

Full BSGSX performance history →

What BSGSX costs

On a $10,000 investment, BSGSX's 1.1% expense ratio costs about $110 a year. The prospectus estimates $1,425 in total costs over 10 years (assuming 5% annual returns). The median mid-cap fund charges 0.88%.

See the full BSGSX fee table →

BSGSX top 10 holdings

#Holding% of fund
1First American Government Obli3.61%
2Neurocrine Biosciences Inc NBIX3.26%
3Curtiss-Wright Corp CW3.24%
4Twist Bioscience Corp TWST3.05%
5Victoria's Secret & Co VSXY2.73%
6Dutch Bros Inc BROS2.66%
7FTAI Aviation Ltd FTAI2.63%
8Twilio Inc TWLO2.51%
9UL Solutions Inc ULS2.28%
10Woodward Inc WWD2.24%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 28.2% of the fund. See all top 25 holdings and asset mix →

Alternatives to BSGSX

More funds like BSGSX →

BSGSX FAQ

What is the expense ratio of BSGSX?
BSGSX's expense ratio is 1.1%, which works out to about $110 a year for every $10,000 invested. The prospectus estimates total costs of $1,425 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is BSGSX a good investment?
It depends on your goals, but the data points to: 5-year return in the bottom quarter of its category; 12b-1 marketing fee of 0.25% a year. This is general information, not personalized advice.
What does BSGSX hold?
BSGSX's largest holdings are First American Government Obli (3.6%), Neurocrine Biosciences Inc (3.3%), Curtiss-Wright Corp (3.2%), Twist Bioscience Corp (3.1%), Victoria's Secret & Co (2.7%). It holds 58 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is BSGSX's 5-year return?
BSGSX returned −1.4% a year over the five years ending Dec 31, 2025. Past performance does not guarantee future results.
Who manages BSGSX?
BSGSX is offered by Baird through Baird Funds Inc.